Michael Derby - Mar 9, 2023 Form 4 Insider Report for PaxMedica, Inc. (PXMD)

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Stock symbol
PXMD
Transactions as of
Mar 9, 2023
Transactions value $
-$3,064
Form type
4
Date filed
3/9/2023, 08:47 PM
Previous filing
Mar 7, 2023
Next filing
Apr 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Sale -$3.06K -2.14K -0.66% $1.43 324K Mar 9, 2023 Direct F1, F2
holding PXMD Common Stock 7.34M Mar 9, 2023 TardiMed Sciences, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan. Shares were sold by the Reporting Person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of restricted stock units granted to the Reporting Person.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $1.54 to $1.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The reporting person is the Managing Partner of TardiMed and has sole voting and dispositive control over the shares of Common Stock held by the entity. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.